Ototoxicity clinical trials at UC Health
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.